American National Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.9K | Buy |
+1,300
| New | +$49.9K | 0.01% | 380 |
|
|
2024
Q3 | – | Sell |
-410
| Closed | -$15.8K | – | 515 |
|
|
2024
Q2 | $15.8K | Buy |
410
+193
| +89% | +$7.43K | ﹤0.01% | 427 |
|
|
2024
Q1 | $9.3K | Hold |
217
| – | – | ﹤0.01% | 421 |
|
|
2023
Q4 | $8.04K | Sell |
217
-2,188
| -91% | -$81.1K | ﹤0.01% | 417 |
|
|
2023
Q3 | $87.2K | Sell |
2,405
-122
| -5% | -$4.42K | 0.01% | 231 |
|
|
2023
Q2 | $90.1K | Buy |
2,527
+2,320
| +1,121% | +$82.7K | 0.02% | 225 |
|
|
2023
Q1 | $7.37K | Sell |
207
-7
| -3% | -$249 | ﹤0.01% | 421 |
|
|
2022
Q4 | $8K | Buy |
+214
| New | +$8K | ﹤0.01% | 397 |
|
|
2022
Q3 | – | Sell |
-202
| Closed | -$11K | – | 606 |
|
|
2022
Q2 | $11K | Buy |
+202
| New | +$11K | ﹤0.01% | 289 |
|
|
2016
Q2 | – | Sell |
-214
| Closed | -$11K | – | 252 |
|
|
2016
Q1 | $11K | Hold |
214
| – | – | ﹤0.01% | 174 |
|
|
2015
Q4 | $11K | Hold |
214
| – | – | ﹤0.01% | 188 |
|
|
2015
Q3 | $10K | Buy |
+214
| New | +$10K | ﹤0.01% | 197 |
|